These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 19525458)

  • 1. Changes in HER2 expression in breast cancer xenografts after therapy can be quantified using PET and (18)F-labeled affibody molecules.
    Kramer-Marek G; Kiesewetter DO; Capala J
    J Nucl Med; 2009 Jul; 50(7):1131-9. PubMed ID: 19525458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [18F]FBEM-Z(HER2:342)-Affibody molecule-a new molecular tracer for in vivo monitoring of HER2 expression by positron emission tomography.
    Kramer-Marek G; Kiesewetter DO; Martiniova L; Jagoda E; Lee SB; Capala J
    Eur J Nucl Med Mol Imaging; 2008 May; 35(5):1008-18. PubMed ID: 18157531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 68Ga-DOTA-affibody molecule for in vivo assessment of HER2/neu expression with PET.
    Kramer-Marek G; Shenoy N; Seidel J; Griffiths GL; Choyke P; Capala J
    Eur J Nucl Med Mol Imaging; 2011 Nov; 38(11):1967-76. PubMed ID: 21748382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential of PET to predict the response to trastuzumab treatment in an ErbB2-positive human xenograft tumor model.
    Kramer-Marek G; Gijsen M; Kiesewetter DO; Bennett R; Roxanis I; Zielinski R; Kong A; Capala J
    J Nucl Med; 2012 Apr; 53(4):629-37. PubMed ID: 22410461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging of human epidermal growth factor receptor type 2 expression with 18F-labeled affibody molecule ZHER2:2395 in a mouse model for ovarian cancer.
    Heskamp S; Laverman P; Rosik D; Boschetti F; van der Graaf WT; Oyen WJ; van Laarhoven HW; Tolmachev V; Boerman OC
    J Nucl Med; 2012 Jan; 53(1):146-53. PubMed ID: 22173842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET imaging of a
    Xu Y; Wang L; Pan D; Yu C; Mi B; Huang Q; Sheng J; Yan J; Wang X; Yang R; Yang M
    Br J Radiol; 2019 Dec; 92(1104):20190425. PubMed ID: 31593482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three methods for 18F labeling of the HER2-binding affibody molecule Z(HER2:2891) including preclinical assessment.
    Glaser M; Iveson P; Hoppmann S; Indrevoll B; Wilson A; Arukwe J; Danikas A; Bhalla R; Hiscock D
    J Nucl Med; 2013 Nov; 54(11):1981-8. PubMed ID: 24115530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the first
    Honarvar H; Müller C; Cohrs S; Haller S; Westerlund K; Karlström AE; van der Meulen NP; Schibli R; Tolmachev V
    Nucl Med Biol; 2017 Feb; 45():15-21. PubMed ID: 27837664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [
    Lu Y; Li M; Massicano AVF; Song PN; Mansur A; Heinzman KA; Larimer BM; Lapi SE; Sorace AG
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33809310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 2-helix small protein labeled with 68Ga for PET imaging of HER2 expression.
    Ren G; Zhang R; Liu Z; Webster JM; Miao Z; Gambhir SS; Syud FA; Cheng Z
    J Nucl Med; 2009 Sep; 50(9):1492-9. PubMed ID: 19690041
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Kwon LY; Scollard DA; Reilly RM
    Mol Pharm; 2017 Feb; 14(2):492-501. PubMed ID: 28049295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the selection of a tracer for PET imaging of HER2-expressing tumors: direct comparison of a 124I-labeled affibody molecule and trastuzumab in a murine xenograft model.
    Orlova A; Wållberg H; Stone-Elander S; Tolmachev V
    J Nucl Med; 2009 Mar; 50(3):417-25. PubMed ID: 19223403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET of HER2-positive pulmonary metastases with 18F-ZHER2:342 affibody in a murine model of breast cancer: comparison with 18F-FDG.
    Kramer-Marek G; Bernardo M; Kiesewetter DO; Bagci U; Kuban M; Aras O; Zielinski R; Seidel J; Choyke P; Capala J
    J Nucl Med; 2012 Jun; 53(6):939-46. PubMed ID: 22582046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET of EGFR expression with an 18F-labeled affibody molecule.
    Miao Z; Ren G; Liu H; Qi S; Wu S; Cheng Z
    J Nucl Med; 2012 Jul; 53(7):1110-8. PubMed ID: 22689926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron-Emission Tomography of HER2-Positive Breast Cancer Xenografts in Mice with
    Al-Saden N; Lam K; Chan C; Reilly RM
    Mol Pharm; 2018 Aug; 15(8):3383-3393. PubMed ID: 29957952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of HER2-expressing tumors with a site-specifically 99mTc-labeled recombinant affibody molecule, ZHER2:2395, with C-terminally engineered cysteine.
    Ahlgren S; Wållberg H; Tran TA; Widström C; Hjertman M; Abrahmsén L; Berndorff D; Dinkelborg LM; Cyr JE; Feldwisch J; Orlova A; Tolmachev V
    J Nucl Med; 2009 May; 50(5):781-9. PubMed ID: 19372467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of HER2-expressing tumors using 111In-ABY-025, a second-generation affibody molecule with a fundamentally reengineered scaffold.
    Ahlgren S; Orlova A; Wållberg H; Hansson M; Sandström M; Lewsley R; Wennborg A; Abrahmsén L; Tolmachev V; Feldwisch J
    J Nucl Med; 2010 Jul; 51(7):1131-8. PubMed ID: 20554729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optical imaging with her2-targeted affibody molecules can monitor hsp90 treatment response in a breast cancer xenograft mouse model.
    van de Ven SM; Elias SG; Chan CT; Miao Z; Cheng Z; De A; Gambhir SS
    Clin Cancer Res; 2012 Feb; 18(4):1073-81. PubMed ID: 22235098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in vivo evaluation of technetium and iodine labels on an anti-HER2 affibody for single-photon imaging of HER2 expression in tumors.
    Orlova A; Nilsson FY; Wikman M; Widström C; Ståhl S; Carlsson J; Tolmachev V
    J Nucl Med; 2006 Mar; 47(3):512-9. PubMed ID: 16513621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small-animal PET imaging of human epidermal growth factor receptor type 2 expression with site-specific 18F-labeled protein scaffold molecules.
    Cheng Z; De Jesus OP; Namavari M; De A; Levi J; Webster JM; Zhang R; Lee B; Syud FA; Gambhir SS
    J Nucl Med; 2008 May; 49(5):804-13. PubMed ID: 18413392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.